Successful Treatment of Alopecia Totalis with Tofacitinib in a Danish Patient

In 2020, a case report detailed the successful treatment of Alopecia Totalis (AT), a condition characterized by extensive hair loss on the scalp, in a 43-year-old male patient using tofacitinib, a Janus kinase inhibitor. Traditional treatments for AT were often ineffective, making this a potentially new treatment modality. After six months of treatment with tofacitinib, the patient regained all his hair, and no relapse was observed after one year of treatment.